Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Metro Bank surges as Pollen Street said to have made takeover approach

(Sharecast News) - Metro Bank shares surged on Monday following reports over the weekend that it has been approached by private equity firm Pollen Street Capital about a possible takeover. According to Sky News, Metro was approached in the last fortnight about an offer to take it private spearheaded by the financial services-focused buyout firm.

Pollen Street is one of the major shareholders in Shawbrook, the mid-sized bank which in the past has approached Metro Bank about a merger of the two companies.

According to Sky, in recent months, Shawbrook's owners have stepped up efforts to identify a prospective corporate combination, holding tentative talks with Starling Bank about a £5bn tie-up, while also drawing up plans for a stock market listing.

At 0935 BST, Metro Bank shares were up 11.8% at 125.45p.

Metro declined to comment on the report.

Russ Mould, investment director at AJ Bell, said: "Metro Bank has been on a rollercoaster of a journey, becoming one of the fastest growing banking names on the UK high street before going through a rocky patch that resulted in an emergency fundraise.

"Metro has since repositioned itself as a business banking provider and investors have slowly regained confidence in the company. The shares have been on a big run over the past year, albeit only putting them back to a two-year high and still a fraction of 2018 highs.

"With the market now looking more favourably on the business, it's no surprise to see takeover speculation as strategically, Metro Bank is in a much better place. What's unknown is the price that a suitor such as Pollen Street would be prepared to pay, as the shares are not cheap versus earnings expectations for 2025. A suitor would need to take a longer-term view of Metro Bank's potential to warrant paying a big premium to the current market price."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.